The competition among oral GLP-1 small molecules benefits patients in several ways: price competition should lower treatment costs, different pharmacokinetic profiles provide options for patients who don't tolerate one agent, and the pressure to differentiate drives development of improved formulations
Lilly plans on discussing the data with regulators, but no plans to seek approval have been announced, according to a spokesperson
Carmina E, Oberfield SE, Lobo RA
For example: Glutamine fuels immune cells that glutathione protects from oxidative damage
Specifically, some studies have demonstrated that EDCs such as bisphenol A (BPA), di-2-ethylhexyl phthalate (DEHP), dibutyl phthalate (DBP), and pesticides exert some of their endocrine-disrupting activity by influencing methylation patterns